Trouble viewing this e-mail?
Click here to view in your web browser

Full Prescribing Information | Visit Website

Dear Healthcare Provider,

We are excited to announce that Rigel Pharmaceuticals is now the manufacturer and distributor for GAVRETO.

Effective July 1, 2024, GAVRETO is available through Rigel’s commercial network and its patient support center, RIGEL ONECARE.

1-833-RIGELOC (744-3562)
Monday-Friday 8 am to 8 pm ET

Please visit RigelONECARE.com to enroll your current or new patients for GAVRETO support.

RIGEL ONECARE has a staff of nurses fully trained to support patients prescribed GAVRETO. Services provided by RIGEL ONECARE include:

	Transitioning existing patients into Rigel network pharmacies
	Benefits investigation, prior authorization, and appeals resources
	Copay assistance*
	Temporary and long-term free drug supply*
	Adherence support and product-education phone calls

For ordering information and a list of Specialty Distributors and Specialty Pharmacies:

Download the GAVRETO Distribution Guide

Visit GAVRETO-hcp.com for more information.

For any medical inquiries, or to report product complaints or adverse events regarding GAVRETO, please contact Rigel Medical Communications Center at 1-800-983-1329 or producthelp@rigel.com.

*	All RIGEL ONECARE programs are subject to eligibility requirements and changes. Criteria above do not represent all criteria for each program. Must be U.S. resident or U.S. territory resident. Restrictions apply.

If you prefer not to receive further messages from this sender, please click here and confirm your request.

IQVIA
10255 W‍. Higgins Ro‍ad, Sui‍te 280
Rosemont, IL 60018

© 2024 Rigel Pharmaceuticals, Inc. All rights reserved.
GAV_PAN-24037 0724
GAVRETO and RIGEL ONECARE are registered trademarks of Rigel Pharmaceuticals, Inc.
RIGEL ONECARE is a patient support center sponsored by Rigel Pharmaceuticals, Inc.
611 Gateway Blvd, Suite 900, South San Francisco, CA 94080